ConductScience.org, home

Paper40539804

Critical amino acid residues in human ACE2 for SARS-CoV-2 spike protein binding and virus entry.

Chen W and 9 others. Microbiol Spectr, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Critical amino acid residues in human ACE2 for SARS-CoV-2 spike protein binding and virus entry. Papers, record 40539804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40539804

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Critical amino acid residues in human ACE2 for SARS-CoV-2 spike protein binding and virus entry.
PubMed
Journal
Microbiol Spectr
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.53, provisional
iCite
Revised in PubMed
2026-10-27
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen WWeiyihttps://orcid.org/0000-0003-3175-2718
2Lee J-YJoo-Youn
3Kim J-SJae-Sung
4Shin JSJin Soo
5Fung TSTo Sing
6Yeh J-YJung-Yonghttps://orcid.org/0000-0002-0939-7783
7Chen ZZhenhaihttps://orcid.org/0000-0002-6704-7546
8Zhou BBinhttps://orcid.org/0000-0001-7279-9489
9Song J-JJi-Joon
10Go YYYun Younghttps://orcid.org/0000-0003-0907-2265

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Spike Glycoprotein, CoronavirusMajor topic
Angiotensin-Converting Enzyme 2Major topic
Virus InternalizationMajor topic
SARS-CoV-2Major topic
Humans
Amino Acid Substitution
Protein Binding
Molecular Dynamics Simulation
COVID-19
Mutagenesis, Site-Directed
Receptors, Virus

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
KK2432-10Korea Research Institute of Chemical TechnologyPubMed
CAP23011-200National Research Council of Science and TechnologyPubMed
RS-2024-00344154National Research Foundation of KoreaPubMed

Source PubMed

Download CSV of grants

References88

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133580154Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection.Commun Biol2021https://conductscience.org/library/papers/33580154PubMed
232747721Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19.Acta Pharmacol Sin2020https://conductscience.org/library/papers/32747721PubMed
333892621SARS-CoV-2 in animals: potential for unknown reservoir hosts and public health implications.Vet Q2021https://conductscience.org/library/papers/33892621PubMed
434139177Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species.Cell2021https://conductscience.org/library/papers/34139177PubMed
536652990Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population.Nat Med2023https://conductscience.org/library/papers/36652990PubMed
632755673SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus.Travel Med Infect Dis2020https://conductscience.org/library/papers/32755673PubMed
736689489Effect of polymorphism in Rhinolophus affinis ACE2 on entry of SARS-CoV-2 related bat coronaviruses.PLoS Pathog2023https://conductscience.org/library/papers/36689489PubMed
832847856SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig.J Virol2020https://conductscience.org/library/papers/32847856PubMed
937954960Exploring the disruption of SARS-CoV-2 RBD binding to hACE2.Front Chem2023https://conductscience.org/library/papers/37954960PubMed
1034582502Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction.PLoS One2021https://conductscience.org/library/papers/34582502PubMed
1138442025Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion.Protein Cell2024https://conductscience.org/library/papers/38442025PubMed
1236163676SARS-CoV-2 infection in dogs and cats is associated with contact to COVID-19-positive household members.Transbound Emerg Dis2022https://conductscience.org/library/papers/36163676PubMed
1332201080Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection.Biochem Biophys Res Commun2020https://conductscience.org/library/papers/32201080PubMed
1433846513Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.Commun Biol2021https://conductscience.org/library/papers/33846513PubMed
1533285566Key residues influencing binding affinities of 2019-nCoV with ACE2 in different species.Brief Bioinform2021https://conductscience.org/library/papers/33285566PubMed
1616510163Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.Virology2006https://conductscience.org/library/papers/16510163PubMed
1734818667The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.Nature2022https://conductscience.org/library/papers/34818667PubMed
1834428371Key Interacting Residues between RBD of SARS-CoV-2 and ACE2 Receptor: Combination of Molecular Dynamics Simulation and Density Functional Calculation.J Chem Inf Model2021https://conductscience.org/library/papers/34428371PubMed
1932362314A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.Mol Cell2020https://conductscience.org/library/papers/32362314PubMed
2033189768Peptide and peptide-based inhibitors of SARS-CoV-2 entry.Adv Drug Deliv Rev2020https://conductscience.org/library/papers/33189768PubMed

See all 88 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42198738Bat-Borne Viruses and Pandemic Risk: Could Europe Be an Emergence Hotspot?Viruses2026https://conductscience.org/library/papers/42198738PubMed
41615206Computational and experimental identification of potential neutralizing peptides derived from human ACE2 against SARS-CoV-2 infection.J Virol2026https://conductscience.org/library/papers/41615206PubMed
41097380Computational Discovery of Potent Nucleoprotein Inhibitors for Influenza A Virus: Validation Through QM/MM Analysis and Experimental Binding Assays.Molecules2025https://conductscience.org/library/papers/41097380PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ACE259272PubTator's text mininghttps://conductscience.org/library/genes/59272

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40539804

GET https://conductscience.org/api/papers/v1/40539804/references?page=2